Big pharma Merck, Bristol Myers, J&J prepare to lose revenue

Fast-approaching patent expirations will take a bite out of revenues and put the industry's top players in the hot seat over the next few years.

Related Keywords

Chris Schott , Matt Phipps , Jpmorgan Schott , Johnson Stelara , Robert Davis , Daiichi Sankyo , Bristol Myers Squibb Opdivo , Merck Keytruda , Bristol Myers Squibb Eliquis , Abbvie Humira , Piper Sandler , Christopher Raymond , Bristol Myers Squibb , Samsung , William Blair Company , Johnson , Jpmorgan Health Care Conference , Wall Street , Myers Squibb , Leerink Partners , Health Care Conference , Karuna Therapeutics , Sel Hardy , Arda Ural , Inflation Reduction Act , Business , Biotechnology , Biotech And Pharmaceuticals , Pharmaceuticals , Health Care Industry , Merck Amp Co Inc , Bristol Myers Squibb Co , Johnson Amp , Breaking News , Abbvie Inc , Moderna Inc , Teva Pharmaceutical Industries Ltd , Karuna Therapeutics Inc , Alvotech Sa , Daiichi Sankyo Co Ltd , Amgen Inc , Business News ,